drugset / Trial / NCT05284656
Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease
RandomizedParallel-groupOpen-labelPrevention
Summary
The aim of this study is to evaluate the effect of administration of folic acid and /or pentoxifylline on patients with chronic kidney disease (CKD).
Timeline
- Start
- 2022-01-08
- Primary completion
- 2026-06-12
- Completion
- 2026-12-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pentoxifylline | Small molecule | 400 mg | — |
| Subject | folic acid | Other / unclassified | 500 ug | — |
| Subject | folic acid | Other / unclassified | 5 mg | — |